Could a daily eating window shield kidneys in diabetes?
NCT ID NCT06884059
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This trial investigates whether time-restricted eating (TRE) — eating all food within an 8-10 hour window each day — can improve kidney function in people with type 2 diabetes who have elevated protein in their urine (microalbuminuria). All 25 participants follow the same TRE schedule while continuing their usual diabetes care. The study measures changes in urine albumin levels and blood sugar control over the intervention period.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- time-restricted eating (TRE) — consuming all food within an 8-10 hour daily window
- What this could lead to
- If it works, this could point toward a simple dietary strategy to protect kidney health in people with type 2 diabetes.
- What could go wrong
- This is a small, early-phase trial with only 25 participants and no control group, so results may not be generalizable. The effect on kidney function may be modest or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROALBUMINURIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altman Clinical and Translational Research Institute
RECRUITINGLa Jolla, California, 92093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Student pharmacists may hold the key to better diabetes control in older asian adults
- Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
- New Dual-Action drug aims to tackle fatty liver where semaglutide falls short
- Can a 12-Week exercise program boost brain and body health in older adults with diabetes?
- Diabetes drugs may shield against severe pneumonia outcomes
- Saliva test could spot hidden links between diabetes and gum disease